The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
Researchers at the Technion – Israel Institute of Technology have developed an artificial intelligence (AI) model designed to help guide whether to administer chemotherapy directly after tumor resection in breast cancer patients. The model, which uses high-resolution images from hematoxylin and eosin (H&E)-stained tumor samples collected at the time of diagnosis, predicts both the risk of cancer recurrence and the likelihood that a patient will benefit from chemotherapy. The research, published in The Lancet Oncology, identifies patterns and signals in the tumor that might otherwise escape detection. “These are complex biological signals that the human eye cannot consistently quantify,” said…
By now, this has become a daily challenge: how many hours of sleep can one get in a night riddled with air-raid alerts, racing to shelter and attempts at shuteye before being woken up again. And not just how many hours in total, but also how long one can sleep uninterrupted. All this comes before the real challenge – staying awake during the day, functioning as normally as possible and perhaps even forgetting – until the next siren – that this is an open-ended state of emergency. This reality has direct and indirect health implications, some immediate and clearly felt…
Six international companies are relocating to Boston as part of an artificial intelligence health care accelerator backed by the Middle East’s largest medical center. Sheba Medical Center in Israel — which has the world’s first AI-powered emergency department — first announced its new U.S. endeavor last May. Now it has officially launched the ARC Innovation Boston location in the city’s downtown, a “soft landing pad” for international startups working to transform the delivery of health care through AI and digital solutions. The Boston hub is joining a network of existing ARC (Accelerate, Redesign, Collaborate) programs in London, Melbourne, Singapore, Berlin…
Researchers at the Technion — Israel Institute of Technology have developed a first-of-its-kind 3D engineered tissue implant that combines muscle and fat tissue with both blood vessels and a lymphatic network, a step they say could eventually help treat patients with major tissue loss from injuries, burns or cancer surgery. The findings were published in the journal Cell Biomaterials by an international team led by the Levenberg Laboratory in the Faculty of Biomedical Engineering at the Technion-Israel Institute of Technology. The current standard treatment for significant tissue loss is an autologous flap, in which tissue is taken from one part…
When Dr. Katrien Vandoorne first arrived in Israel to pursue her PhD at the Weizmann Institute of Science, she was struck by something that went far beyond laboratories and research facilities. “The people were very collaborative and warm and inspiring,” she recalled. “The science was really great for me, but also the Mediterranean climate, the food, all those things.” Originally from Belgium, Vandoorne said the country’s scientific culture felt very different from the academic environment she had known in Europe. “In Belgium it’s very hierarchical,” she said. “The professor is very high up, and you should always be very polite…
From regenerative implants to smarter therapies, Israel’s innovation ecosystem keeps delivering life-saving advances. Researchers from Haifa’s Technion – Israel Institue of Technology unveiled a breakthrough biological implant that could end daily insulin injections for millions with Type 1 diabetes by producing insulin inside the body without rejection. Hebrew University discovered a tiny RNA molecule that bacteriophages use to combat bacteria, offering fresh hope in the fight against antibiotic-resistant “superbugs.”
Artificial intelligence is so much more than the latest buzzword. By blurring the line between human and technology, AI has proven its staying power and will undoubtedly shape the future of life on Earth. It is also no secret that when it comes to AI innovation, Israel punches above its weight class. I recently called upon the brightest minds in Israel to take an active role in shaping AI applications on a global scale, setting ethical standards and ensuring that this technology is used for good. When I think of Israel’s AI prowess, I can’t help but place the Technion…
Seeing a Different Kind of Picture While Prof. Bekenstein is transforming how images are detected, Prof. Kaminer is redefining how they are created. His project, known as Stork, addresses a longstanding limitation of transmission electron microscopes — tools essential for studying biological tissues and advanced materials. These microscopes often struggle with low-contrast images, making it […]
A new implant developed at the Technion – Israel Institute of Technology may offer a self-regulating treatment for diabetes, according to a new study in collaboration with MIT, Harvard, Johns Hopkins University, and the University of Massachusetts. The study, led by Assistant Professor Shady Farah of the Faculty of Chemical Engineering at the Technion, was peer-reviewed and was published in Science. It introduced a “living, cell-based implant” that works as a pancreas and is protected against immune rejection by a novel system. According to the statement, the implant “continuously senses blood-glucose levels, produces insulin within the implant itself, and releases…
At the Zimin Institute for AI Solutions in Health Care, innovation meets impact. Founded in 2022 through a partnership between the Zimin Foundation and the Technion’s Tech.AI.BioMed arm, the institute supports transformative research that applies artificial intelligence to real-world medical challenges. From diagnostics to drug discovery and patient care, AI is redefining what’s possible in […]
Led by a repeat founder and a world-renowned robotics pioneer, the Israeli startup EndoCure has developed a robotic platform capable of producing 3D images with 10 times the density of an MRI. “Current imaging methods, MRI, CT, and manual ultrasound, often fail to detect small or deep tumors, are highly operator-dependent, and are either expensive, invasive, or inconsistent,” says EndoCure. “This creates major gaps in diagnosis, delays in treatment, unnecessary surgeries, and poor patient outcomes.” Founded in 2023 by Dr. Hadas Ziso, a repeat founder with 20 years of MedTech experience, and Prof. Moshe Shoham, a robotics pioneer who was…
What if a single breath — or a small wearable patch — could reveal disease long before symptoms appear? For years, Prof. Hossam Haick of the Technion – Israel Institute of Technology has been turning that revolutionary idea into a reality. By identifying invisible chemical signals emitted by the human body, Prof. Haick has helped […]